VCM
AQST icon

Voleon Capital Management’s Aquestive Therapeutics AQST Stock Holding History

Voleon Capital Management’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$173K Buy
+41,561
New +$175K ﹤0.01% 736
2026
Q1 		– Sell
-14,044
Closed -$90.7K – 792
2025
Q4 		$90.7K Buy
+14,044
New +$87.5K ﹤0.01% 754

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Voleon Capital Management's AQST Position: Q2 2026 in Review

Voleon Capital Management opened a new position in Aquestive Therapeutics (AQST) in Q2 2026: 41,561 shares worth $173K. The stake represents ﹤0.01% of the portfolio and ranks #736 among its holdings. This is a return to the name: Voleon Capital Management previously reported a position in AQST as recently as Q4 2025.

Voleon Capital Management first reported a position in AQST in Q4 2025 and has held it in 2 quarters since. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Voleon Capital Management held 41,561 shares of Aquestive Therapeutics worth $173K as of Q2 2026.
  • Aquestive Therapeutics was a new Voleon Capital Management position in Q2 2026.
  • Aquestive Therapeutics made up ﹤0.01% of Voleon Capital Management's portfolio in Q2 2026, its #736 holding.
  • Voleon Capital Management first reported a position in Aquestive Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.